Home
Jazz Pharmaceuticals JAZZ paid Tiber Creek Group $60K for lobbying in Q1 2023 · Health Issues, Medical and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q1 2023
- Client
- Jazz Pharmaceuticals
- Reported
- 23/04/16
Up 0.0% from last quarter
What else happened in Jazz Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/03/01~23/04/30Jazz Pharmaceuticals's other lobbying reports
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$80K
$80K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$490K
$490K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/20
for Q2
- Jazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
LobbyingJazz Pharmaceuticals
JAZZ
$50K
$50K
Reported 07/19
for Q2